Cost-effectiveness of hydroxychloroquine versus placebo for hand osteoarthritis: economic evaluation of the HERO trial

Ronaldson, SJ, Keding, A, Tharmanathan, P et al. (4 more authors) (2021) Cost-effectiveness of hydroxychloroquine versus placebo for hand osteoarthritis: economic evaluation of the HERO trial. F1000Research, 10. 821. p. 821. ISSN 2046-1402

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2021 Ronaldson SJ et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: economic evaluation, hand osteoarthritis, hydroxychloroquine, randomised controlled trial, cost-effectiveness analysis, cost-utility analysis
Dates:
  • Accepted: 3 August 2021
  • Published (online): 17 August 2021
  • Published: 17 August 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 Oct 2021 12:30
Last Modified: 06 Oct 2021 12:30
Status: Published
Publisher: F1000 Research
Identification Number: https://doi.org/10.12688/f1000research.55296.1

Share / Export

Statistics